Cellid (299660.KQ) Financials
299660.KQ Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 51.3 billion | 21.3 billion |
2023-06-30 | 31.0 billion | 15.6 billion |
2023-03-31 | 34.9 billion | 15.9 billion |
2022-12-31 | 45.9 billion | 23.4 billion |
299660.KQ Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -7.5 billion | 413.0 million |
2023-06-30 | -3.7 billion | 73.7 million |
2023-03-31 | -1.7 billion | 99.5 million |
2022-12-31 | -2.8 billion | 90.2 million |
299660.KQ Net Income
No data available :(
299660.KQ Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | - | - | 15.2 million |
2023-06-30 | 8.0 billion | - | 23.8 million |
2023-03-31 | 9.3 billion | 4.5 million | 34.1 million |
2022-12-31 | 18.7 billion | 8.9 million | 52.3 million |
299660.KQ Shares Outstanding
299660.KQ Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 4.9 billion | 832.3 million | 466.1 million | - |
2023-06-30 | 863.8 million | 1.8 billion | 1.2 billion | - |
2023-03-31 | 35.5 million | 1.4 billion | 1.3 billion | - |
2022-12-31 | 1.2 billion | 694.2 million | 1.2 billion | - |
299660.KQ Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | 480.0 million | 324.5 million |
299660.KQ
Price: ₩3,670
52 week price:
Exchange: KOE
Sector: Health Technology
Industry: Pharmaceuticals: Major
Market Capitalization: 52.2 billion